February 12, 2024

Molecular Phenotypes of Acute Respiratory Distress Syndrome in the ROSE Trial Have Differential Outcomes and Gene Expression Patterns That Differ at Baseline and Longitudinally over Time

Key Points

Key points are not available for this paper at this time.

Abstract

Two molecular phenotypes have been identified in acute respiratory distress syndrome (ARDS). In the ROSE (Reevaluation of Systemic Early Neuromuscular Blockade) trial of cisatracurium in moderate to severe ARDS, we addressed three unanswered questions:

Bookmark

Cite This Study

Sinha et al. (Mon,) studied this question.

synapsesocial.com/papers/68e796dbb6db643587707b4e https://doi.org/https://doi.org/10.1164/rccm.202308-1490oc

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials2023 · 185 citations
2Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis2022 · 101 citations
3Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials2014 · 1,530 citations
4Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study2016 · 828 citations
5Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis1997 · 3,550 citations

Bookmark